Beta-lactam dose reductions in critically ill patients with acute kidney injury: a scoping review - Top-Institutions - MDSpire

Beta-lactam dose reductions in critically ill patients with acute kidney injury: a scoping review

  • By

  • M. M.B. Horstink

  • W. J.R. Rietdijk

  • D. R. Geel

  • P. E. Deetman

  • H. Endeman

  • B. C.P. Koch

  • C. A. den Uil

  • December 2, 2025

  • 0 min

Share

Top Institutions in Nephrology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Critical Care Medicine
    • Nephrology
    • Infectious Diseases
    • Clinical Pharmacology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Critical Care Medicine
    • Nephrology
    • Infectious Diseases

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Critical Care Medicine
    • Nephrology
    • Pharmacology

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Critical Care Medicine
    • Nephrology
    • Infectious Diseases

  • #5

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Critical Care Medicine
    • Nephrology
    • Pharmacology

Original Source(s)

Beta-lactam dose reductions in critically ill patients with acute kidney injury: a scoping review

  • by M. M.B. Horstink, W. J.R. Rietdijk, D. R. Geel, P. E. Deetman, H. Endeman, B. C.P. Koch, C. A. den Uil

  • December 2, 2025

Related Content

Correlation of Shock-Lactate Index with 28-Day Mortality in Patients Experiencing Sepsis-Related AKI: An Analysis Using the MIMIC-IV Database

Association between baseline-stratified trajectory subgroups of serum albumin and outcomes in critically ill patients with early sepsis-associated acute kidney injury: a retrospective study

Polymyxin B-induced acute kidney injury in a burn patient: a case report and pharmaceutical care